IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
16 hedge funds and large institutions have $704K invested in Interpace Biosciences, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$212K | |
| 2 | +$104K | |
| 3 | +$96K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$87.9K |
| 5 |
JPMorgan Chase & Co
New York
|
+$37K |
Top Sellers
| 1 | -$292K | |
| 2 | -$108K | |
| 3 | -$64K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.19K |